Your shopping cart is currently empty

Apstatin is an effective inhibitor of aminopeptidase P (APP), exhibiting Ki values of 2.6 µM for rat APP and 0.64 µM for human APP. Additionally, Apstatin has cardioprotective properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | Apstatin is an effective inhibitor of aminopeptidase P (APP), exhibiting Ki values of 2.6 µM for rat APP and 0.64 µM for human APP. Additionally, Apstatin has cardioprotective properties. |
| In vivo | Administering Apstatin (1 mg/kg; i.v.; 5 min before ischemia) has been shown to significantly reduce the infarct size (IS) in an acute myocardial ischemia model. This model utilized male Wistar rats weighing between 270-310 g. The compound was injected intravenously 5 minutes prior to inducing ischemia, demonstrating its effectiveness in decreasing myocardial infarction area in this context. |
| Molecular Weight | 459.54 |
| Formula | C23H33N5O5 |
| Cas No. | 160470-73-5 |
| Smiles | C(=O)([C@H]1N(C([C@H]([C@@H](CC2=CC=CC=C2)N)O)=O)CCC1)N3[C@H](C(N[C@H](C(N)=O)C)=O)CCC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.